Skip to main content
$3.75 $0.25 (7.1%)

04:00 PM EDT on 07/01/22

Vaxart, Inc (NASDAQ:VXRT)

CAPS Rating: 1 out of 5

Current Price $3.75 Mkt Cap $474.2M
Open $3.49 P/E Ratio 0.00
Prev. Close $3.75 Div. (Yield) $0.00 (0.0%)
Daily Range $3.47 - $3.75 Volume 2,057,699
52-Wk Range $2.49 - $10.33 Avg. Daily Vol. 3,046,242

Caps

How do you think NASDAQ:VXRT will perform against the market?

Add Stock to CAPS Watchlist

All Players

35 Outperform
23 Underperform
 

All-Star Players

4 Outperform
17 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:VXRT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

PeteRock69 (< 20)
Submitted April 25, 2021

The Bears are hyper-focused on the lack of antibody response and totally dismissing the importance/value of increased T-cell response. Oral vaccines will be an absolute game changer.

TMFjimhalley (28.11)
Submitted December 15, 2020

The company's valuation is too high considering that its oral COVID-19 vaccine candidate hasn't been approved. The clinical-stage biotech company is still looking for a blockbuster therapy and considering its lack of earnings, doesn't rate its… More

NASDAQ:VXRT Summary

Fools bullish on NASDAQ:VXRT are also bullish on:

Fools bearish on NASDAQ:VXRT are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about VXRT.

Recs

2
Member Avatar PeteRock69 (< 20) Submitted: 4/25/2021 9:10:37 AM : Outperform Start Price: $5.68 NASDAQ:VXRT Score: -26.12

The Bears are hyper-focused on the lack of antibody response and totally dismissing the importance/value of increased T-cell response. Oral vaccines will be an absolute game changer.

Recs

3
Member Avatar TMFbonefish (37.98) Submitted: 12/16/2020 6:51:06 PM : Outperform Start Price: $7.60 NASDAQ:VXRT Score: -53.77

It's a gamble but the upside of a tablet based vaccine, especially for the seasonal flu, is immense. I think the upside outweighs the potential downside.

Recs

2
Member Avatar TMFjimhalley (28.11) Submitted: 12/14/2020 9:47:21 PM : Underperform Start Price: $8.02 NASDAQ:VXRT Score: +57.57

The company's valuation is too high considering that its oral COVID-19 vaccine candidate hasn't been approved. The clinical-stage biotech company is still looking for a blockbuster therapy and considering its lack of earnings, doesn't rate its current share price.

Leaderboard

Find the members with the highest scoring picks in VXRT.

Score Leader

portefeuille

portefeuille (98.06) Score: +384.74

The Score Leader is the player with the highest score across all their picks in VXRT.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
portefeuille 98.06 4/29/2019 Outperform 5Y $0.72 +414.65% +29.92% +384.74 0 Comment
NorteClub 89.93 7/29/2020 Underperform 5Y $11.30 -67.21% +18.38% +85.59 0 Comment
deepcrisis 99.49 3/9/2018 Underperform 5Y $5.98 -38.04% +37.24% +75.29 0 Comment
JoeySolitro1 99.99 3/9/2018 Underperform 5Y $5.80 -36.12% +37.75% +73.87 0 Comment
ChiefPaw 50.30 5/17/2018 1/22/2019 Underperform 1Y $5.09 -27.16% +40.22% +67.38 1 Comment
XMFZhiyuanSun < 20 2/4/2021 Underperform 1Y $9.94 -62.73% -0.43% +62.30 0 Comment
TMFjimhalley 28.11 12/15/2020 Underperform 3M $8.02 -53.78% +3.79% +57.57 1 Comment
PLAZMASTOX 39.42 4/17/2020 Outperform 1Y $1.95 +90.41% +33.62% +56.79 0 Comment
BigCaps18 94.77 12/23/2020 Underperform 5Y $6.88 -46.15% +3.54% +49.69 0 Comment
GabrielSevrs 32.28 6/14/2021 Underperform 3W $9.20 -59.73% -10.16% +49.57 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for VXRT.